Instability of non standard microsatellites in metastatic colorectal cancer patients treated with a bevacizumab based chemotherapy

被引：0
|
作者：
Pirini, Francesca [1 ]
Pasini, Luigi [1 ]
Ravaioli, Sara [1 ]
Tedaldi, Gianluca [1 ]
Scarpi, Emanuela [1 ]
Marisi, Giorgia [1 ]
Molinari, Chiara [1 ]
Calistri, Daniele [1 ]
Passardi, Alessandro [1 ]
Ulivi, Paola [1 ]
机构：
[1] IRCCS, IRST, SRL, Meldola, Italy
来源：
CANCER RESEARCH | 2020年 / 80卷 / 16期
关键词：
D O I：
10.1158/1538-7445.AM2020-5296
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5296
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients
    Pirini, Francesca
    Pasini, Luigi
    Tedaldi, Gianluca
    Scarpi, Emanuela
    Marisi, Giorgia
    Molinari, Chiara
    Calistri, Daniele
    Passardi, Alessandro
    Ulivi, Paola
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (10)
  • [2] Bevacizumab or standard chemotherapy in previously treated patients with metastatic colorectal cancer - a systematic review
    Kaczor, Marcin
    Staskiewicz, Wojciech
    Homa, Monika
    Gorecka, Magdalena
    Wojcik, Rafal
    Potemski, Piotr
    ONCOLOGY IN CLINICAL PRACTICE, 2021, 17 (01): : 14 - 27
  • [3] Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?
    Grothey, A
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (01): : 22 - 23
  • [4] Bevacizumab plus chemotherapy in metastatic colorectal cancer patients treated in clinical practice
    Rossi, Luigi
    Veltri, Enzo
    Zullo, Angelo
    Zoratto, Federica
    Colonna, Maria
    Di Seri, Marisa
    Longo, Flavia
    Mottolese, Marcella
    Giannarelli, Diana
    Ruco, Luigi
    Romiti, Adriana
    Barucca, Viola
    Adua, Daniela
    Tomao, Silverio
    FUTURE ONCOLOGY, 2012, 8 (09) : 1193 - 1197
  • [5] Does bevacizumab improve survival in patients with metastatic colorectal cancer treated with chemotherapy?
    Axel Grothey
    Nature Clinical Practice Oncology, 2006, 3 : 22 - 23
  • [6] Assessment of tumor-infiltrating lymphocytes in metastatic colorectal cancer patients treated by Bevacizumab-based chemotherapy
    Spano, J. P.
    Gobert, A.
    Mateescu, C.
    Mouawad, R.
    Bardier, A.
    Bachet, J. B.
    Dubreuilh, O.
    Varinot, J.
    Mitri, R.
    Khayat, D.
    Malouf, G.
    Capron, F.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S347 - S348
  • [7] Cyclophilin A: An Independent Prognostic Factor for Survival in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab and Chemotherapy
    Moisuc, Diana Cornelia
    Constantinescu, Daniela
    Marinca, Mihai Vasile
    Gafton, Bogdan
    Pavel-Tanasa, Mariana
    Cianga, Petru
    CANCERS, 2024, 16 (02)
  • [8] Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
    P Österlund
    L-M Soveri
    H Isoniemi
    T Poussa
    T Alanko
    P Bono
    British Journal of Cancer, 2011, 104 : 599 - 604
  • [9] Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab
    Passardi, Alessandro
    Azzali, Irene
    Bittoni, Alessandro
    Marisi, Giorgia
    Rebuzzi, Francesca
    Molinari, Chiara
    Bartolini, Giulia
    Matteucci, Laura
    Sullo, Francesco Giulio
    Debonis, Silvia Angela
    Gallio, Chiara
    Monti, Manlio
    Valgiusti, Martina
    Muratore, Margherita
    Rapposelli, Ilario Giovanni
    Ulivi, Paola
    Frassineti, Giovanni Luca
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [10] Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapy
    Oesterlund, P.
    Soveri, L. -M
    Isoniemi, H.
    Poussa, T.
    Alanko, T.
    Bono, P.
    BRITISH JOURNAL OF CANCER, 2011, 104 (04) : 599 - 604
12345